Review



clp257  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    MedChemExpress clp257
    Muscimol or <t>CLP257</t> dose-dependently inhibits RIH. (A, B) PWMT were evaluated at −24 h (baseline) and 4 h, 8 h, 16 h and 24 h after remifentanil administration. Data were expressed as percent change from the baseline (mean ± SD) ( n = 6). (C, E) Bands of western blot for the expression of GABAAα2R or KCC2 at 24 h after remifentanil administration. (D, F) The fold change for the density of GABAAα2R or KCC2 normalized to the GAPDH level. Data were expressed as mean ± SD ( n = 4). ** p < 0.01 group C; # p < 0.05 or ## p < 0.01 versus group RI; $ p < 0.05 or $$ p < 0.01 versus group low; & p < 0.05 or && p < 0.01 versus group medium.
    Clp257, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/clp257/product/MedChemExpress
    Average 90 stars, based on 1 article reviews
    clp257 - by Bioz Stars, 2026-02
    90/100 stars

    Images

    1) Product Images from "KCC2 receptor upregulation potentiates antinociceptive effect of GABAAR agonist on remifentanil-induced hyperalgesia"

    Article Title: KCC2 receptor upregulation potentiates antinociceptive effect of GABAAR agonist on remifentanil-induced hyperalgesia

    Journal: Molecular Pain

    doi: 10.1177/17448069221082880

    Muscimol or CLP257 dose-dependently inhibits RIH. (A, B) PWMT were evaluated at −24 h (baseline) and 4 h, 8 h, 16 h and 24 h after remifentanil administration. Data were expressed as percent change from the baseline (mean ± SD) ( n = 6). (C, E) Bands of western blot for the expression of GABAAα2R or KCC2 at 24 h after remifentanil administration. (D, F) The fold change for the density of GABAAα2R or KCC2 normalized to the GAPDH level. Data were expressed as mean ± SD ( n = 4). ** p < 0.01 group C; # p < 0.05 or ## p < 0.01 versus group RI; $ p < 0.05 or $$ p < 0.01 versus group low; & p < 0.05 or && p < 0.01 versus group medium.
    Figure Legend Snippet: Muscimol or CLP257 dose-dependently inhibits RIH. (A, B) PWMT were evaluated at −24 h (baseline) and 4 h, 8 h, 16 h and 24 h after remifentanil administration. Data were expressed as percent change from the baseline (mean ± SD) ( n = 6). (C, E) Bands of western blot for the expression of GABAAα2R or KCC2 at 24 h after remifentanil administration. (D, F) The fold change for the density of GABAAα2R or KCC2 normalized to the GAPDH level. Data were expressed as mean ± SD ( n = 4). ** p < 0.01 group C; # p < 0.05 or ## p < 0.01 versus group RI; $ p < 0.05 or $$ p < 0.01 versus group low; & p < 0.05 or && p < 0.01 versus group medium.

    Techniques Used: Western Blot, Expressing

    The additive effects of CLP257 with muscimol in the reversion of pathogenesis of RIH. (A) PWMT was evaluated at −24 h (baseline) and 4 h, 8 h, 16 h and 24 h after remifentanil administration. Data were expressed as percent change from the baseline (mean ± SD) ( n = 6). (B) Bands of western blot for the expression of KCC2, pKCC2, GABAAα2R and c-fos at 24 h. (C) The fold change for the density of KCC2, GABAAα2R or c-fos normalized to the GAPDH level. Data were expressed as mean ± SD ( n = 4). * p < 0.05 or ** p < 0.01 versus group C; # p < 0.05 or ## p < 0.01 versus group RI; $ p < 0.05 or $$ p < 0.01 versus group Mus; & p < 0.05 or && p < 0.01 versus group CLP.
    Figure Legend Snippet: The additive effects of CLP257 with muscimol in the reversion of pathogenesis of RIH. (A) PWMT was evaluated at −24 h (baseline) and 4 h, 8 h, 16 h and 24 h after remifentanil administration. Data were expressed as percent change from the baseline (mean ± SD) ( n = 6). (B) Bands of western blot for the expression of KCC2, pKCC2, GABAAα2R and c-fos at 24 h. (C) The fold change for the density of KCC2, GABAAα2R or c-fos normalized to the GAPDH level. Data were expressed as mean ± SD ( n = 4). * p < 0.05 or ** p < 0.01 versus group C; # p < 0.05 or ## p < 0.01 versus group RI; $ p < 0.05 or $$ p < 0.01 versus group Mus; & p < 0.05 or && p < 0.01 versus group CLP.

    Techniques Used: Western Blot, Expressing



    Similar Products

    clp257  (MedChemExpress)
    90
    MedChemExpress clp257
    Muscimol or <t>CLP257</t> dose-dependently inhibits RIH. (A, B) PWMT were evaluated at −24 h (baseline) and 4 h, 8 h, 16 h and 24 h after remifentanil administration. Data were expressed as percent change from the baseline (mean ± SD) ( n = 6). (C, E) Bands of western blot for the expression of GABAAα2R or KCC2 at 24 h after remifentanil administration. (D, F) The fold change for the density of GABAAα2R or KCC2 normalized to the GAPDH level. Data were expressed as mean ± SD ( n = 4). ** p < 0.01 group C; # p < 0.05 or ## p < 0.01 versus group RI; $ p < 0.05 or $$ p < 0.01 versus group low; & p < 0.05 or && p < 0.01 versus group medium.
    Clp257, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/clp257/product/MedChemExpress
    Average 90 stars, based on 1 article reviews
    clp257 - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Muscimol or CLP257 dose-dependently inhibits RIH. (A, B) PWMT were evaluated at −24 h (baseline) and 4 h, 8 h, 16 h and 24 h after remifentanil administration. Data were expressed as percent change from the baseline (mean ± SD) ( n = 6). (C, E) Bands of western blot for the expression of GABAAα2R or KCC2 at 24 h after remifentanil administration. (D, F) The fold change for the density of GABAAα2R or KCC2 normalized to the GAPDH level. Data were expressed as mean ± SD ( n = 4). ** p < 0.01 group C; # p < 0.05 or ## p < 0.01 versus group RI; $ p < 0.05 or $$ p < 0.01 versus group low; & p < 0.05 or && p < 0.01 versus group medium.

    Journal: Molecular Pain

    Article Title: KCC2 receptor upregulation potentiates antinociceptive effect of GABAAR agonist on remifentanil-induced hyperalgesia

    doi: 10.1177/17448069221082880

    Figure Lengend Snippet: Muscimol or CLP257 dose-dependently inhibits RIH. (A, B) PWMT were evaluated at −24 h (baseline) and 4 h, 8 h, 16 h and 24 h after remifentanil administration. Data were expressed as percent change from the baseline (mean ± SD) ( n = 6). (C, E) Bands of western blot for the expression of GABAAα2R or KCC2 at 24 h after remifentanil administration. (D, F) The fold change for the density of GABAAα2R or KCC2 normalized to the GAPDH level. Data were expressed as mean ± SD ( n = 4). ** p < 0.01 group C; # p < 0.05 or ## p < 0.01 versus group RI; $ p < 0.05 or $$ p < 0.01 versus group low; & p < 0.05 or && p < 0.01 versus group medium.

    Article Snippet: Both muscimol (M1523, Sigma-Aldrich, St Louis, MO, USA, dissolved in 0.05 M HCl) and CLP257 (HY-110,143, MedChemExpress, Monmouth Junction, NJ, USA, dissolved in 1% DMSO) were intrathecally injected through intrathecal catheter.

    Techniques: Western Blot, Expressing

    The additive effects of CLP257 with muscimol in the reversion of pathogenesis of RIH. (A) PWMT was evaluated at −24 h (baseline) and 4 h, 8 h, 16 h and 24 h after remifentanil administration. Data were expressed as percent change from the baseline (mean ± SD) ( n = 6). (B) Bands of western blot for the expression of KCC2, pKCC2, GABAAα2R and c-fos at 24 h. (C) The fold change for the density of KCC2, GABAAα2R or c-fos normalized to the GAPDH level. Data were expressed as mean ± SD ( n = 4). * p < 0.05 or ** p < 0.01 versus group C; # p < 0.05 or ## p < 0.01 versus group RI; $ p < 0.05 or $$ p < 0.01 versus group Mus; & p < 0.05 or && p < 0.01 versus group CLP.

    Journal: Molecular Pain

    Article Title: KCC2 receptor upregulation potentiates antinociceptive effect of GABAAR agonist on remifentanil-induced hyperalgesia

    doi: 10.1177/17448069221082880

    Figure Lengend Snippet: The additive effects of CLP257 with muscimol in the reversion of pathogenesis of RIH. (A) PWMT was evaluated at −24 h (baseline) and 4 h, 8 h, 16 h and 24 h after remifentanil administration. Data were expressed as percent change from the baseline (mean ± SD) ( n = 6). (B) Bands of western blot for the expression of KCC2, pKCC2, GABAAα2R and c-fos at 24 h. (C) The fold change for the density of KCC2, GABAAα2R or c-fos normalized to the GAPDH level. Data were expressed as mean ± SD ( n = 4). * p < 0.05 or ** p < 0.01 versus group C; # p < 0.05 or ## p < 0.01 versus group RI; $ p < 0.05 or $$ p < 0.01 versus group Mus; & p < 0.05 or && p < 0.01 versus group CLP.

    Article Snippet: Both muscimol (M1523, Sigma-Aldrich, St Louis, MO, USA, dissolved in 0.05 M HCl) and CLP257 (HY-110,143, MedChemExpress, Monmouth Junction, NJ, USA, dissolved in 1% DMSO) were intrathecally injected through intrathecal catheter.

    Techniques: Western Blot, Expressing